Quantitative Tomographic Analysis as a Prognostic Tool in Connective Tissue Disease-Associated Interstitial Lung

Camila Vilas Boas Machado1, Pedro Paulo Teixeira da Silva Torres2, Danilo Tadao Wada3

  • 1Department of Medical Imaging, Hematology and Clinical Oncology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto 14015-010, SP, Brazil.

Insights

Quantitative CT analysis aids in evaluating interstitial lung disease (ILD) in connective tissue diseases (CTDs). This method, alongside visual assessment and pulmonary function tests, can track disease progression and functional decline in ILD-CTD patients.

Area of Science:

  • Radiology
  • Pulmonary Medicine
  • Rheumatology

Background:

  • Interstitial lung disease (ILD) is a significant complication of connective tissue diseases (CTDs), leading to high morbidity and mortality.
  • High-resolution computed tomography (HRCT) is the standard for diagnosing and characterizing ILD.
  • Identifying prognostic markers in ILD-CTD is crucial for patient management.

Purpose of the Study:

  • To conduct longitudinal visual and quantitative HRCT analyses in patients with ILD-CTD.
  • To correlate HRCT findings with clinical outcomes, including functional decline and mortality.
  • To identify tomographic prognostic markers for ILD-CTD.

Main Methods:

  • Retrospective, longitudinal study of 195 CTD patients with HRCT scans at baseline and two follow-ups.
  • Collected data included visual ILD extent, subjective progression, quantitative parameters (lung volume, density), and pulmonary function tests (FVC, DLCO).
  • Correlated HRCT findings with patient outcomes (functional decline, death).

Main Results:

  • Moderate agreement between quantitative and visual HRCT assessments of ILD extent.
  • Lung volume variations, ground-glass index, and vascular volume ratio correlated with perceived disease progression.
  • Reduced lung volume and increased disease extent predicted FVC decrease at follow-up 1; increased fibrosis index predicted FVC decrease at follow-up 2.
  • No quantitative CT parameter predicted mortality risk.

Conclusions:

  • Quantitative CT analysis shows potential as a complementary tool for longitudinal ILD-CTD evaluation.
  • Combining quantitative CT with pulmonary function tests and visual analysis offers a comprehensive approach.
  • This integrated approach can improve the monitoring of disease progression and functional status in ILD-CTD.